MicroRNAs associated with mitogen-activated protein kinase in human pancreatic cancer

Yushi Ikeda1, Etsuko Tanji, Naohiko Makino

  • 1International Research and Educational Institute for Integrated Medical Sciences, Tokyo Women's Medical University, Tokyo, Japan.

Insights

Mitogen-activated protein kinase (MAPK) pathway activation influences microRNA (miRNA) expression in pancreatic cancer. This study identified specific miRNAs regulated by MAPK, with miR-193b showing significant potential to inhibit cancer cell proliferation.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • Aberrant microRNA (miRNA) expression is linked to pancreatic cancer phenotypes.
  • The mechanisms driving miRNA dysregulation in pancreatic cancer remain largely unknown.
  • The mitogen-activated protein kinase (MAPK) signaling pathway is implicated in pancreatic cancer progression.

Purpose of the Study:

  • To investigate the role of MAPK signaling in the aberrant expression of miRNAs in pancreatic cancer cells.
  • To identify specific miRNAs regulated by MAPK activity.
  • To assess the impact of MAPK-associated miRNAs on pancreatic cancer cell proliferation.

Main Methods:

  • Quantitative real-time PCR was used to assay expression changes of 183 miRNAs.
  • MAPK activation and inactivation were induced in cultured pancreatic cancer cells and HEK293 cells.
  • Promoter assays and reporter assays were employed to validate gene regulation and target suppression.

Main Results:

  • Four miRNAs (miR-7-3, miR-34a, miR-181d, miR-193b) were significantly associated with MAPK activity.
  • miR-7-3 was upregulated by active MAPK; miR-34a, miR-181d, and miR-193b were downregulated.
  • Overexpression of these miRNAs inhibited pancreatic cancer cell proliferation, with miR-193b showing the strongest effect.
  • CCND1, NT5E, PLAU, STARD7, STMN1, and YWHAZ were identified as miR-193b targets.

Conclusions:

  • MAPK signaling plays a significant role in the aberrant expression of miRNAs in pancreatic cancer.
  • MAPK-regulated miRNAs contribute to pancreatic cancer phenotypes.
  • miR-193b demonstrates potential as a therapeutic agent by inhibiting cancer cell proliferation and targeting key genes.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...